dc.contributor.author |
Sh.A. Bobokulova , Sh.A. Khamdamov , D.N. Korikhonov , 1 2 3 A.O. Okhunov4, K.Kh Boboev5, F.A. Abdurakhmanov6 |
|
dc.date.accessioned |
2023-02-11T02:45:08Z |
|
dc.date.available |
2023-02-11T02:45:08Z |
|
dc.date.issued |
2023-01 |
|
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/6286 |
|
dc.description.abstract |
Background. The COVID-19 pandemic has shown how much coronavirus infection can be contagious. Even now, doctors are fac ing the consequences of this viral disease. A high lesion of the pulmonary system causes an increase in the proportion of conse quences of respiratory disease. One of the difficult aspects in this direction is lung abscesses.
Material. An analysis of different approaches in the treatment of lung abscesses of patients who have had COVID-19 was carried
out. All patients, depending on the severity of the course of purulent lung disease and treatment methods, were divided into 3
groups.
Results. The main positive therapeutic effect in the treatment of lung abscesses in patients who have had COVID-19 should be re duced to the impact of the effects of endothelitis. For this purpose, long-term intraarterial catheter therapy and local ultrasound cavi tation of the lung destruction cavity were used. Significant positive results were obtained in all major groups where a differentiated
treatment approach was applied. |
en_US |
dc.language.iso |
en |
en_US |
dc.subject |
acute lung abscesses, COVID-19, endothelialitis, long-term intraarterial catheter therapy, ultrasound cavitation |
en_US |
dc.title |
How to Treat Acute Purulent-Destructive Lung Dis eases if they are Sequels to Covid-19? Problems and ways to solve them. |
en_US |
dc.type |
Article |
en_US |